Roche Holding AG Participation

$433.58-$20.42 (4.5%)

Estimate

P/E

22.9

EPS

18.93

Beta

0.347

Forecast

P/E (FWD)

20.4

EPS (FWD)

21.29

Dividends

Dividend yield

2.9%

Annual payout

$12.58

Next ex. div date

March 13, 27

Payout

60.02%

Div.growth, 5y

4.98%

Dividend growth streak

7 y

Div.rating

About the company

Ticker

RHHVF

ISIN

CH0012032048

Country

Switzerland

Sector (GICS)

Healthcare

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.

Frequently asked questions

What sector does Roche Holding AG Participation (RHHVF) operate in?

Roche Holding AG Participation belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Roche Holding AG Participation (RHHVF) current stock price?

As of the latest data, Roche Holding AG Participation stock price is $433.58, with a previous close of $454.00. Roche Holding AG Participation lost -$20.42 in the last trading session, representing a -4.5% loss.

What is Roche Holding AG Participation (RHHVF) current market capitalization?

Roche Holding AG Participation market cap is approximately 299.20 billion.

What is Roche Holding AG Participation (RHHVF) Earnings Per Share (EPS)?

The trailing EPS is $18.93, and the forward EPS is $21.29.

What is Roche Holding AG Participation (RHHVF) Price-to-Earnings (P/E) ratio?

Roche Holding AG Participation current P/E ratio is 22.9, with a forward P/E of 20.37.

Does Roche Holding AG Participation (RHHVF) pay dividends?

Yes. Roche Holding AG Participation pays annual dividends with an annualized yield of 2.9% and an estimated annual payout of $12.58 per share.

When is the next ex-dividend date for Roche Holding AG Participation (RHHVF)?

The next ex-dividend date is scheduled for March 13, 2027.

When is Roche Holding AG Participation (RHHVF) next earnings report?

Roche Holding AG Participation is expected to release its next earnings report on June 30, 2026.

What is Roche Holding AG Participation (RHHVF) beta (volatility) score?

Roche Holding AG Participation has a beta of 0.347, indicating lower volatility than the overall market.